Fundz

Cardiff Oncology Appoints Dr. Leila Alland as Interim Chief Medical Officer

PUBLIC · CRDFOct 27, 2026

Position

Chief Medical Officer

Company

Cardiff Oncology

Dr. Leila Alland
San DiegoBiotechnologyHealth CareScience And Engineering

Description

Effective October 23, 2026, Dr. Leila Alland has been appointed as the interim Chief Medical Officer of Cardiff Oncology, Inc. following the departure of Dr

Who to call at Cardiff Oncology, and when

A new leader at Cardiff Oncology brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Cardiff Oncology raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Cardiff Oncology, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Cardiff Oncology. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Cardiff Oncology

Location

11055 Flintkote Avenue

San Diego, California, United States

About

Cardiff Oncology is a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers. The Company's lead asset is onvansertib, a PLK1 inhibitor being evaluated in combination with standard of care (SoC) therapeutics in clinical programs targeting indications such as RAS-mutated metastatic colorectal cancer (mCRC), as well as in ongoing and planned investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma (mPDAC), small cell lung cancer (SCLC) and triple negative breast cancer (TNBC). These programs and the Company's broader development strategy are designed to target tumor vulnerabilities in order to overcome treatment resistance and deliver superior clinical benefit compared to the SoC alone.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Cardiff Oncology changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Roger
Likely contact at this company
••••••••@••••••••

See Roger's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Cardiff Oncology's next move

Learn about Strategic plan

Cardiff Oncology changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.